Cargando…
tRNA-derived fragments as novel potential biomarkers for relapsed/refractory multiple myeloma
BACKGROUND: tRNA-derived fragments have been reported to be key regulatory factors in human tumors. However, their roles in the progression of multiple myeloma remain unknown. RESULTS: This study employed RNA-sequencing to explore the expression profiles of tRFs/tiRNAs in new diagnosed MM and relaps...
Autores principales: | Xu, Cong, Liang, Ting, Zhang, Fangrong, Liu, Jing, Fu, Yunfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111751/ https://www.ncbi.nlm.nih.gov/pubmed/33971811 http://dx.doi.org/10.1186/s12859-021-04167-8 |
Ejemplares similares
-
Expression Profiles of tRNA-Derived Fragments and Their Potential Roles in Multiple Myeloma
por: Xu, Cong, et al.
Publicado: (2021) -
Efficacy and Safety of CAR-T Therapy for Relapse or Refractory Multiple Myeloma: A systematic review and meta-analysis
por: Yang, Qin, et al.
Publicado: (2021) -
Carfilzomib for relapsed and refractory multiple myeloma
por: Groen, K, et al.
Publicado: (2019) -
Treatment of relapsed and refractory multiple myeloma
por: Lee, Ji Hyun, et al.
Publicado: (2020) -
Selinexor in relapsed/refractory multiple myeloma
por: Richter, Joshua, et al.
Publicado: (2020)